Generally speaking 10mg-20mg is a fine dosing to serve any female purpose with 20mg per day being as far as most will want to go. While it is a mild steroid virilization probability can increase a fair amount when this dosing level is surpassed. Most women are highly advised to begin with 10mg per day and often this is all the Anavar they will ever need. If more is needed to achieve the desired result make sure you can handle the lower dose first before increasing it and if you do increase it you should use extreme caution and pay close attention to your body as to ensure virilization does not occur. In most cases 6 weeks of use will prove to be just about perfect with 8 weeks being about as long as most will want to go. If you need or desire more time it is advised you discontinue use for 4-6 weeks before beginning another course.
It is true, Anavar is a very female friendly, and for the vast majority of women if they keep their use at a responsible level they will experience no virilization symptoms. However, if your dose goes too high, you can guarantee the Anavar results you see will not be the ones you desire. Further, and this is extremely important to remember, because we are all unique individuals, we will all respond to the hormone in a unique way. For this reason, some women, even with responsible use may fall prey to virilization symptoms. If this occurs, and if the woman discontinues use as soon as the symptoms begin to show they will fade away, and she will be fine.
Anticoagulants: Patients on anticoagulants such as warfarin should be carefully monitored during anabolic steroid therapy as anabolic steroids may increase sensitivity to oral anticoagulants which may require a concomitant reduction in anticoagulant dosage to achieve a desirable prothrombin time (PT). Anticoagulant patients should be monitored regularly during anabolic steroid therapy, particularly during initiation and termination of therapy. Warfarin patients should have INR and PT monitored throughout androgen therapy and warfarin dosages titrated to achieve the desired INR and PT. Such patients should be monitored for occult bleeding.